CLINICAL EVALUATION OF COMBINATION IMMUNOTHERAPY FOR RENAL CELL CARCINOMA (RCC)

$2,124,536FY2025Defense Health AgencyDOD

Mayo Clinic, Rochester MN

Investigators

View source on USAspending →